Evidence map›Paper›PMID 36683818›Full record

ArticleFrontiers in pediatrics2022

Case report: Cystic fibrosis with kwashiorkor: A rare presentation in the era of universal newborn screening.

Annemarie G Wolfe, Stephanie P Gilley, Stephanie W Waldrop, Christina Olson, Emma Harding, Kaitlin Widmer, Lindsey B Gumer, Matthew Haemer, Jordana E Hoppe

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Annemarie G WolfeDepartment of Pediatrics, University of Colorado Denver Anschutz Medical Campus, Aurora, CO, United States.
Stephanie P GilleyDepartment of Pediatrics, University of Colorado Denver Anschutz Medical Campus, Aurora, CO, United States.
Stephanie W WaldropDepartment of Pediatrics, University of Colorado Denver Anschutz Medical Campus, Aurora, CO, United States.
Christina OlsonDepartment of Pediatrics, University of Colorado Denver Anschutz Medical Campus, Aurora, CO, United States.
Emma HardingDepartment of Pediatrics, University of Colorado Denver Anschutz Medical Campus, Aurora, CO, United States.
Kaitlin WidmerDepartment of Pediatrics, University of Colorado Denver Anschutz Medical Campus, Aurora, CO, United States.
Lindsey B GumerDepartment of Pediatrics, University of Colorado Denver Anschutz Medical Campus, Aurora, CO, United States.
Matthew HaemerDepartment of Pediatrics, University of Colorado Denver Anschutz Medical Campus, Aurora, CO, United States.
Jordana E HoppeDepartment of Pediatrics, University of Colorado Denver Anschutz Medical Campus, Aurora, CO, United States.
University of Colorado Denver · USUniversity of Colorado Anschutz Medical Campus · US

Funding

NIDDK National Research Service Award (NRSA) T32 Diversity Administrative SupplementT32DK007658 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Kristen Elizabeth Boyle, Ihuoma U Eneli · 1991 to 2026
$6.0M
NIDDK NIH HHS T32 DK007658
6 · The paper itself

Abstract

Background: Universal newborn screening changed the way medical providers think about the presentation of cystic fibrosis (CF). Before implementation of universal screening, it was common for children with CF to present with failure to thrive, nutritional deficiencies, and recurrent infections. Now, nearly all cases of CF are diagnosed by newborn screening shortly after birth before significant symptoms develop. Therefore, providers often do not consider this illness in the setting of a normal newborn screen. Newborn screening significantly decreases the risk of complications in early childhood, yet definitive testing should be pursued if a patient with negative newborn screening presents with symptoms consistent with CF, including severe failure to thrive, metabolic alkalosis due to significant salt losses, or recurrent respiratory infections. Case presentation: We present a case of a 6-month-old infant male with kwashiorkor, severe edema, multiple vitamin deficiencies, hematemesis secondary to coagulopathy, and diffuse erythematous rash, all secondary to severe pancreatic insufficiency. His first newborn screen had an immunoreactive trypsinogen (IRT) value below the state cut-off value, so additional testing was not performed, and his growth trajectory appeared reassuring. He was ultimately diagnosed with CF by genetic testing and confirmatory sweat chloride testing, in the setting of his parents being known CF carriers and his severe presentation being clinically consistent with CF. Acutely, management with supplemental albumin, furosemide, potassium, and vitamin K was initiated to correct the presenting hypoalbuminemia, edema, and coagulopathy. Later, pancreatic enzyme supplementation and additional vitamins and minerals were added to manage ongoing deficiencies from pancreatic insufficiency. With appropriate treatment, his vitamin deficiencies and edema resolved, and his growth improved. Conclusion: Due to universal newborn screening, symptomatic presentation of CF is rare and presentation with kwashiorkor is extremely rare in resource-rich communities. The diagnosis of CF was delayed in our patient because of a normal newborn screen and falsely reassuring growth, which after diagnosis was determined to be secondary to severe edematous malnutrition. This case highlights that newborn screening is a useful but imperfect tool. Clinicians should continue to have suspicion for CF in the right clinical context, even in the setting of normal newborn screen results.

Indexed as

cystic fibrosis - CFkwashiorkormissed diagnosisnewborn screening (NBS)pancreatic insufficiency

Identifiers

PMID36683818
PMCPMC9853421
OpenAlexW4313641538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.